BEELINE: 10.1038/s41592-019-0690-6 source data published 2020

What this source contributed

Records in this release that cite this source. A record can cite several sources.

• 12 configurations
• 4 protocols
• 4 dataset subsets
• 48 evaluations
• 180 results
• 42 evidence claims

Results

Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.

Claims

Statements this source supports, each with where in the source it was checked.

• BEELINE 2020 Figure 4 · GSD: description: Description Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: name: Name BEELINE 2020 Figure 4 · GSD (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: panel[0].caveats[0]: Comparison panels[0]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: panel[0].title: Comparison panels[0]: title BEELINE 2020 Figure 4 · GSD: AUPRC Ratio (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: panel[1].caveats[0]: Comparison panels[1]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: panel[1].title: Comparison panels[1]: title BEELINE 2020 Figure 4 · GSD: Early Precision Ratio (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: panel[2].caveats[0]: Comparison panels[2]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: panel[2].title: Comparison panels[2]: title BEELINE 2020 Figure 4 · GSD: EPR Activation (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: panel[3].caveats[0]: Comparison panels[3]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · GSD: panel[3].title: Comparison panels[3]: title BEELINE 2020 Figure 4 · GSD: EPR Inhibition (Figure 4 source CSV row 3, column 5)
• BEELINE 2020 Figure 4 · HSC: description: Description Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: name: Name BEELINE 2020 Figure 4 · HSC (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: panel[0].caveats[0]: Comparison panels[0]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: panel[0].title: Comparison panels[0]: title BEELINE 2020 Figure 4 · HSC: AUPRC Ratio (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: panel[1].caveats[0]: Comparison panels[1]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: panel[1].title: Comparison panels[1]: title BEELINE 2020 Figure 4 · HSC: Early Precision Ratio (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: panel[2].caveats[0]: Comparison panels[2]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: panel[2].title: Comparison panels[2]: title BEELINE 2020 Figure 4 · HSC: EPR Activation (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: panel[3].caveats[0]: Comparison panels[3]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · HSC: panel[3].title: Comparison panels[3]: title BEELINE 2020 Figure 4 · HSC: EPR Inhibition (Figure 4 source CSV row 3, column 4)
• BEELINE 2020 Figure 4 · mCAD: description: Description Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 2)
• BEELINE 2020 Figure 4 · mCAD: name: Name BEELINE 2020 Figure 4 · mCAD (Figure 4 source CSV row 3, column 2)
• BEELINE 2020 Figure 4 · mCAD: panel[0].caveats[0]: Comparison panels[0]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 2)
• BEELINE 2020 Figure 4 · mCAD: panel[0].title: Comparison panels[0]: title BEELINE 2020 Figure 4 · mCAD: AUPRC Ratio (Figure 4 source CSV row 3, column 2)
• BEELINE 2020 Figure 4 · mCAD: panel[1].caveats[0]: Comparison panels[1]: caveats[0] Source-specific evaluation. No equivalence to other releases, protocols or model families is inferred. (Figure 4 source CSV row 3, column 2)

Models, benchmarks and other records

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.